0 NASDAQ Companies - February 20, 2019Xeris Pharmaceuticals to Participate at SVB Leerink Global Healthcare ConferenceRead More
0 TSX Venture News - February 20, 2019Eguana Exercises Right to Acquire Limited Partnership UnitsRead More
0 NASDAQ Companies - February 20, 2019Clearside Biomedical Receives Notification of FDA Acceptance of NDA Filing for XIPERE™ (triamcinolone acetonide ophthalmic suspension) for Suprachoroidal Injection with PDUFA Date Set for October 19, 2019Read More
0 NYSE Companies - February 20, 2019Medtronic Announces U.S. Commercial Launch of Deep Brain Stimulation for Medically-Refractory EpilepsyRead More
0 NYSE Companies - February 20, 2019Five SolarWinds Leaders Recognized as 2019 CRN Channel ChiefsRead More
0 Canadian Stock Exchange News - February 20, 2019Canada House Wellness Group Inc. builds on Sales License, announces new business structure and the launch of its retail divisionRead More
0 NYSE Companies - February 20, 2019Ocwen Financial Corporation Schedules Conference Call – 4th Quarter 2018 ResultsRead More
0 NYSE Companies - February 20, 2019Compass Diversified Holdings Announces Sale of Manitoba Harvest to TilrayRead More
0 NASDAQ Companies - February 20, 2019AC Immune Announces Anti-Tau Monoclonal Antibody Entering Second Phase 2 Trial in Moderate Alzheimer’s DiseaseRead More
